2007. 4¿ù
½Å¾à¼Ò°³     º¸ÇèÁ¤º¸   NEWS
 
 
¿ø³» Ç×Áø±ÕÁ¦ ºÐ·ù
� °æ±¸¿ë ¾àÁ¦ÀÇ ºÐ·ù
ºÐ·ù ¼ººÐ¸í »óÇ°¸í ¿ë¹ý ÁÖÀÇÁ¡
¹× ±Ý±â
Duration
(hr)
FDA
ÀÎ ½¶ ¸° ºÐ ºñ ⇑ Sulfonylurea
ÃéÀå ¥â¼¼Æ÷¿¡¼­ insulin ºÐºñÁõ°¡
Ç÷û glucagon ³óµµ °¨¼Ò
Insulin receptor ¼öÀÇ Áõ°¡
1 ¼¼ ´ë Acetohexamide   500~750mg
qd~bid
1Çü ´ç´¢È¯ÀÚ
¼ÒÈ­±âÀå¾Ö
ÀúÇ÷´çÁõ
½ÅÁúȯ/°£Àå¾Ö (ȯÀÚ¿¡ Ä¡¸íÀû)
Ç÷¾×ÇÐÀû ÀÌ»ó
ºó¸Æ
12
~
24
C
Chlorpropamide   250~375mg
qd
24
~
60
C
Tolazmide   250~375mg
qd~bid
12
~
24
C
Tolbutamide   1~1.5g
bid~tid
6
~
12
C
2 ¼¼ ´ë Glimepiride Amaryl
2mg
1~6mg
/day am ac
(max:
8mg/day)
24 C
Glipizide   10mg
qd~bid
¾à¹°»óÈ£ÀÛ¿ë )
¥â-Blockers
10
~
24
C
Glyburide   5mg
qd~bid
50 B
Glyclazide Diamicron
MR 30mg
30~120mg
qd am
   
Meglitinide°è :
non SU moiety of glyburide   
¥â-cell¿¡¼­ insulin ºÐºñ ÃËÁø
(¼ÓÈ¿¼º)
Repaglinide Novornorm
1mg
4mg
# 2~4 ac
(max:
16mg/d)
1Çü´ç´¢º´È¯ÀÚ
°£Áúȯ (°£µ¶¼º), ½ÉºÎÀü, Ç÷¾×ÇÐÀûÀÌ»ó
Diabetic ketoacidosis
  C
Nateglinide   120mg
tid ac
ÁÖÀÇ) Á¤»óÇ÷´çÀÎ °æ¿ì ¾àÀ» ¸Ô°í³­ ÈÄ ¹Ù·Î ½Ä»çÇÏÁö ¾ÊÀ¸¸é ÀúÇ÷´ç ¾ß±â   C
´ç Èí ¼ö ⇓ ¥á-Glucosidase inhibitor :
ÀÌź´çÀÇ ºÐÇØ ¾ïÁ¦
Acarbose Glucobay
100mg
100mg
tid ac
(max:
600mg/d)
º¹ºÎÆظ¸, º¹¸í, ¼³»ç, ÀúÇ÷´ç
±Ý±â) IBD, ÀåÆó»ö ȯÀÚ
      Èí¼ö°¡ Àß ¾È µÇ´Â ȯÀÚ
      °£Áúȯ, ½ÅÀåÁúȯ
  B
Miglitol   25~50mg
tid
(max:
300mg/d)
  B
Voglibose  Basen
0.2mg
0.2~0.3mg
tic ac
   
Basen
0.3mg
´Ù¸¥ °æ±¸¾à°ú º´¿ë½Ã ÀúÇ÷´ç¾ß±â
 ¢¡ Æ÷µµ´ç Åõ¿©
´ç »ý »ê ⇓ Biguanide°è :
°£¿¡¼­ ´ç½Å»ý ¾ïÁ¦
¼ÒÈ­±â·ÎºÎÅÍ Æ÷µµ´çÀÇ Èí¼ö ÀúÇØ
ÀåÁ¡¸·¼¼Æ÷¿¡¼­ÀÇ ´çÀÌ¿ë Áõ°¡  ±ÙÀ° ¹× Áö¹æ¼¼Æ÷¿¡¼­
glucose À̵¿Ã¼ È°¼ºÈ­
Metformin Diabex
500mg
500~750mg
/day # 2~3
(max:
2500mg/day)
À¯»êÁõ Lactic acidosis
(°£Áúȯ, ½ÅºÎÀüÁõ, 80¼¼ÀÌ»ó, CHF,  ¾ËÄÝÁßµ¶ÀÚ, ÆÐÇ÷Áõ, ¼ö¼ú µî)
  B
Diabex
1000mg
Sulfony-
lurea
Biguan-
ide°è
Glimepiride
Metformin
Amaryl M
2/500mg
1tab
qd~bid
ac or pc
¾à¹°»óÈ£ÀÛ¿ë)
 Alc. ¢¡ Á¥»ê´ë»ç¿¡ ¿µÇâ
Cimetidine ¢¡ º»Á¦ Ç÷Áß³óµµ 60% ⇑
Á¶ÇüÁ¦  ¢¡ ±Þ¼º½ÅºÎÀü, lactic acid À¯¹ß
   
Gliben-
clamide
Metformin 
Glucovance
500/5mg
Glucovance
1T bid
  B
Àν¶¸°ÀúÇ×¼º ⇓ Thiazolidinedione :
Insulin sensitizers
°£¿¡¼­ ´ç½Å»ý ¾ïÁ¦
¸»Ãʼ¼Æ÷ÀÇ ´ç ÀÌ¿ë·ü Áõ°¡
Rosiglitasone Avandia
4mg
4mg qd Á¦ 1Çü´ç´¢È¯ÀÚ
°£µ¶¼º, ¿ïÇ÷¼º½ÉºÎÀü
Ç÷¾×ÇÐÀûÀÌ»ó
  C
Pioglitazone Actos
15mg
 15mg qd   C
 
�  InsulinÀÇ ºÐ·ù
ºÐ·ù »óÇ°¸í ¼ººÐ∙ÇÔ·® Pharmacokinetics Compatibility of various insulin FDA ºñ°í
T1/2  (h) Onset (h) Peak (h) Dura. (h)
Rapid acting Humalog 10mL Insulin lispro 100IU/mL 1 0.25 0.5~1.5 2~5 Ultralente, NPH B Insulin pump »ç¿ë Áß ÆßÇÁÁ¤Áö½Ã
RIº¸´Ù ´õ »¡¸® °íÇ÷´ç Ketosis »ý±è
Novorin R 10mL Insulin regular   0.5~1   8~12 all B Á¤¸ÆÅõ¿© °¡´É (À¯ÀÏ)
  Prompt insulin zinc suspension (semilente)   1~1.5 5~10 12~16 lente B  
  Insulin aspart solution 1.5 0.25 1~3 3~5   C insulin lispro¿Í ºñ½ÁÇÏ°Ô ½ÄÈÄ Ç÷´çÁ¶Àý
Intermediate acting Novolin N 10mL Isophane insulin suspension (NPH) 100IU/mL   1~1.5 4~12 24 Regular B NPH+RI È¥ÇÕÇصµ º° ¹®Á¦ ¾øÀ½
Nonolet N 3mL
  Insulin zinc suspension (Lente)   1~2.5 7~15 24 Regular, semilente B Lente + RI : ÀÛ¿ë½Ã°£ Áö¿¬ (¡ñ RI ħÀü)
È¥ÇÕÇü Novomix30 Flexpen 3mL Insulin (Aspart) : NPH  = 30 : 70  
cf. Insulin Aspart : ¼ÓÈ¿¼º
          B  
Long acting Lantus optiset 3mL Insulin glargine solution 100IU/mL   1.1 5 24 none C 24½Ã°£¿¡ Çѹø sc
  Protamine Zinc Insulin suspension (PZI)   4~8 14~24 36 Regular B  
  Extended insulin Zinc suspension (Ultralente)   4~8 10~30 20~36 Regular, semilente B Ultralente + RI :   Àν¶¸° Èí¼ö°¡ ªÀº ½Ã°£(5ºÐ ÀÌÇÏ) Áö¿¬
 
¾àÁ¦ºÎ : 051)850-8551~2 / Fax : 051)850-8553